Opportunities and challenges for decentralized clinical trials: European regulators' perspective
AJ de Jong, TI van Rijssel… - Clinical …, 2022 - Wiley Online Library
Decentralized clinical trials (DCTs) have the potential to improve accessibility, diversity, and
retention in clinical trials by moving trial activities to participants' homes and local …
retention in clinical trials by moving trial activities to participants' homes and local …
Discontinuation and non-publication of surgical randomised controlled trials: observational study
SJ Chapman, B Shelton, H Mahmood, JE Fitzgerald… - Bmj, 2014 - bmj.com
Objective To determine the rate of early discontinuation and non-publication of randomised
controlled trials involving patients undergoing surgery. Design Cross sectional observational …
controlled trials involving patients undergoing surgery. Design Cross sectional observational …
Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis
Background Randomised trials (also referred to as 'randomised controlled trials' or 'trials')
are the optimal way to minimise bias in evaluating the effects of competing treatments …
are the optimal way to minimise bias in evaluating the effects of competing treatments …
Intensive triangulation of qualitative research and quantitative data to improve recruitment to randomized trials: the QuinteT approach
L Rooshenas, S Paramasivan… - Qualitative Health …, 2019 - journals.sagepub.com
Randomized controlled trials (RCTs) can provide high quality evidence about the
comparative effectiveness of health care interventions, but many RCTs struggle with or fail to …
comparative effectiveness of health care interventions, but many RCTs struggle with or fail to …
[HTML][HTML] Nonregistration, discontinuation, and nonpublication of randomized trials: A repeated metaresearch analysis
Background We previously found that 25% of 1,017 randomized clinical trials (RCTs)
approved between 2000 and 2003 were discontinued prematurely, and 44% remained …
approved between 2000 and 2003 were discontinued prematurely, and 44% remained …
Systematic review on costs and resource use of randomized clinical trials shows a lack of transparent and comprehensive data
B Speich, B von Niederhäusern, N Schur… - Journal of clinical …, 2018 - Elsevier
Abstract Objectives Randomized clinical trials (RCTs) are costly. We aimed to provide a
systematic overview of the available evidence on resource use and costs for RCTs to …
systematic overview of the available evidence on resource use and costs for RCTs to …
[HTML][HTML] Participant recruitment and retention in remote eHealth intervention trials: methods and lessons learned from a large randomized controlled trial of two web …
Background Despite having many advantages, online eHealth trials are not without
challenges—notably, participant recruitment, and outcome data retention. Moreover …
challenges—notably, participant recruitment, and outcome data retention. Moreover …
[HTML][HTML] Conveying equipoise during recruitment for clinical trials: qualitative synthesis of clinicians' practices across six randomised controlled trials
L Rooshenas, D Elliott, J Wade, M Jepson… - PLoS …, 2016 - journals.plos.org
Background Randomised controlled trials (RCTs) are essential for evidence-based
medicine and increasingly rely on front-line clinicians to recruit eligible patients. Clinicians' …
medicine and increasingly rely on front-line clinicians to recruit eligible patients. Clinicians' …
TECRL, a new life‐threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT
HD Devalla, R Gélinas, EH Aburawi… - EMBO molecular …, 2016 - embopress.org
Genetic causes of many familial arrhythmia syndromes remain elusive. In this study, whole‐
exome sequencing (WES) was carried out on patients from three different families that …
exome sequencing (WES) was carried out on patients from three different families that …
[HTML][HTML] Exploring reasons for recruitment failure in clinical trials: a qualitative study with clinical trial stakeholders in Switzerland, Germany, and Canada
Background Poor participant recruitment is the most frequent reason for premature
discontinuation of randomized clinical trials (RCTs), particularly if they are investigator …
discontinuation of randomized clinical trials (RCTs), particularly if they are investigator …